MAPK8 and myelofibrosis: Finally, to assess the impact of JNK activation on the development of myelofibrosis, we treated WT mice transplanted with MPLW515L-transduced HSPCs with the pan-JNK inhibitor CC-930 (tanzisertib) twice daily for 4 weeks beginning 2 weeks after transplantation.